XML 40 R30.htm IDEA: XBRL DOCUMENT
v3.20.2

Segment Information (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2020
Segment Reporting [Abstract] |
Schedule of segment reporting information |
|  | Three Months Ended June 30, |  |  | Six Months Ended June 30, |
|  | 2020 |  |  | 2019 |  |  | 2020 |  |  | 2019 |
Revenues |  |  |  |  |  |  |  |  |  |  |  |
Real property operations |  | $ | 301,267 |  |  | $ | 264,889 |  |  | $ | 598,223 |  |  | $ | 531,515 |
Medical related consulting services - related parties |  |  | - |  |  |  | 111,434 |  |  |  | - |  |  |  | 125,694 |
Development services and sales of developed products |  |  | - |  |  |  | 23,404 |  |  |  | - |  |  |  | 26,682 |
Total |  |  | 301,267 |  |  |  | 399,727 |  |  |  | 598,223 |  |  |  | 683,891 |
Costs and expenses |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Real property operations |  |  | 272,764 |  |  |  | 192,676 |  |  |  | 527,265 |  |  |  | 423,435 |
Medical related consulting services - related parties |  |  | - |  |  |  | 95,375 |  |  |  | - |  |  |  | 108,466 |
Development services and sales of developed products |  |  | - |  |  |  | 31,784 |  |  |  | - |  |  |  | 62,091 |
Total |  |  | 272,764 |  |  |  | 319,835 |  |  |  | 527,265 |  |  |  | 593,992 |
Gross profit (loss) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Real property operations |  |  | 28,503 |  |  |  | 72,213 |  |  |  | 70,958 |  |  |  | 108,080 |
Medical related consulting services - related parties |  |  | - |  |  |  | 16,059 |  |  |  | - |  |  |  | 17,228 |
Development services and sales of developed products |  |  | - |  |  |  | (8,380 | ) |  |  | - |  |  |  | (35,409 | )
Total |  |  | 28,503 |  |  |  | 79,892 |  |  |  | 70,958 |  |  |  | 89,899 |
Other operating expenses |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Real property operations |  |  | 103,218 |  |  |  | 67,691 |  |  |  | 214,034 |  |  |  | 177,597 |
Medical related consulting services - related parties |  |  | 175,891 |  |  |  | 60,943 |  |  |  | 331,126 |  |  |  | 240,071 |
Development services and sales of developed products |  |  | 30,240 |  |  |  | 222,077 |  |  |  | 66,239 |  |  |  | 442,958 |
Corporate/Other |  |  | 2,721,981 |  |  |  | 4,072,933 |  |  |  | 5,684,578 |  |  |  | 8,038,338 |
Total |  |  | 3,031,330 |  |  |  | 4,423,644 |  |  |  | 6,295,977 |  |  |  | 8,898,964 |
Other income (expense) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Real property operations |  |  | - |  |  |  | (8,219 | ) |  |  | - |  |  |  | (32,877 | )
Corporate/Other |  |  | (42,469 | ) |  |  | (13,242 | ) |  |  | (84,638 | ) |  |  | (16,225 | )
Total |  |  | (42,469 | ) |  |  | (21,461 | ) |  |  | (84,638 | ) |  |  | (49,102 | )
Other income (expense) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Real property operations |  |  | 4 |  |  |  | 7 |  |  |  | (931 | ) |  |  | 15 |
Medical related consulting services - related parties |  |  | (11,091 | ) |  |  | (9,743 | ) |  |  | (16,578 | ) |  |  | (21,854 | )
Development services and sales of developed products |  |  | 1 |  |  |  | 51 |  |  |  | 3 |  |  |  | 179 |
Corporate/Other |  |  | - |  |  |  | (63,925 | ) |  |  | - |  |  |  | (63,925 | )
Total |  |  | (11,086 | ) |  |  | (73,610 | ) |  |  | (17,506 | ) |  |  | (85,585 | )
Total other income (expense) |  |  | (53,555 | ) |  |  | (95,071 | ) |  |  | (102,144 | ) |  |  | (134,687 | )
Net loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Real property operations |  |  | 74,711 |  |  |  | 3,690 |  |  |  | 144,007 |  |  |  | 102,379 |
Medical related consulting services - related parties |  |  | 186,982 |  |  |  | 54,627 |  |  |  | 347,704 |  |  |  | 244,697 |
Development services and sales of developed products |  |  | 30,239 |  |  |  | 230,406 |  |  |  | 66,236 |  |  |  | 478,188 |
Corporate/Other |  |  | 2,764,450 |  |  |  | 4,150,100 |  |  |  | 5,769,216 |  |  |  | 8,118,488 |
Total |  | $ | 3,056,382 |  |  | $ | 4,438,823 |  |  | $ | 6,327,163 |  |  | $ | 8,943,752 |
Identifiable long-lived tangible assets at June 30, 2020 and December 31, 2019 |  | June 30, 2020 |  |  | December 31, 2019 |
Real property operating |  | $ | 7,668,501 |  |  | $ | 7,750,743 |
Medical related consulting services |  |  | 232,914 |  |  |  | 263,621 |
Development services and sales of developed products |  |  | 273,559 |  |  |  | 322,741 |
Total |  | $ | 8,174,974 |  |  | $ | 8,337,105 |
Identifiable long-lived tangible assets at June 30, 2020 and December 31, 2019 |  | June 30, 2020 |  |  | December 31, 2019 |
United States |  | $ | 7,746,413 |  |  | $ | 7,839,093 |
China |  |  | 428,561 |  |  |  | 498,012 |
Total |  | $ | 8,174,974 |  |  | $ | 8,337,105 |

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration